MAM
Vodafone launches second leg of ‘Made for You’ campaign
MUMBAI: Vodafone has launched the second leg of its 121 ‘Made For you‘ campaign, created by Ogilvy & Mather.
Directed by O&M NCD Rajiv Rao, the ad film is produced by Good Morning Films.
According to the company, the first phase established that one can get unique offers of their choice by dialling 121 from their Vodafone mobiles.
“We now extend the campaign offering multiple products. Idea was to showcase the unique usage of certain types of people (heavy talktime, internet or STD users) to communicate the types of offers that are available when you call 121 before you recharge. Full talktime idea was developed keeping in mind a popular guy in college with a need to talk for longer durations. STD and Internet films also take a similar approach reflecting a slice from our day-to-day life and people we meet,” the company said in a statement.
The 121 campaign positioned 121 portal as the one stop shop to get plans/offers customized (Made for You) on the basis of your current usage. The 121 extension campaign brings to life in a direct manner the product possibilities that 121 offers.
The 121 campaign extension will be six week long with three films bringing to life the product propositions on Full talktime, STD & Data. There will be a high decibel 360 media plan using TV, Radio, Print, Outdoor, on-ground, digital and online plan.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
